NCT03362684View on ClinicalTrials.gov

PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

PHASE3CompletedINTERVENTIONAL
Enrollment

1,808

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2009

Study Completion Date

June 30, 2016

Conditions
Colorectal Cancer
Interventions
DRUG

Cetuximab

Cetuximab every 2 weeks

DRUG

FOLFOX

FOLFOX-4 every 2 weeks

Sponsors

Lead Sponsor

IntegraGen SA

Collaborators (1)

Exystat
All Listed Sponsors
collaborator

Federation Francophone de Cancerologie Digestive

OTHER

collaborator

Exystat

OTHER

lead

IntegraGen SA

INDUSTRY